Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26261247

Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2015 Nov 10
First author
Duvic M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2015 Nov 10;33(32):3691-6. doi: 10.1200/JCO.2015.61.9486.
    note
    Source null
    related pmid
    26392103
    relationship
    Comment in

Authors and identifiers

  1. name
    Duvic M
    type
    Author
  2. name
    Tetzlaff MT
    type
    Author
  3. name
    Gangar P
    type
    Author
  4. name
    Clos AL
    type
    Author
  5. name
    Sui D
    type
    Author
  6. name
    Talpur R
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Duvic M
    type
    Author
  2. name
    Tetzlaff MT
    type
    Author
  3. name
    Gangar P
    type
    Author
  4. name
    Clos AL
    type
    Author
  5. name
    Sui D
    type
    Author
  6. name
    Talpur R
    type
    Author
bibliography ids
  1. nci-bib-154896b4f404d295b5f937a1
book metadata
content sha256
24d2a220e9196a89c79a1c1c08da5ef4c35f87b7a112c9deddcab4864b746681
document type
citation
dois
  1. 10.1200/JCO.2014.60.3787
electronic publication date
display
2015 Aug 10
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:26261247
immutable id
pubmed:26261247@24d2a220e9196a89c79a1c1c08da5ef4c35f87b7a112c9deddcab4864b746681
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
32
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3759-65
volume
33
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2015 Nov 10;33(32):3691-6. doi: 10.1200/JCO.2015.61.9486.
    note
    Source null
    related pmid
    26392103
    relationship
    Comment in
outcomes validated
false
pmid
26261247
provenance
batch id
4c1ece5bfc3d8e2be622
provider
NCBI PubMed ESummary
record sha256
097763800ab75a928813c6664f664bcabfc21e979195564db33ecef238378ed4
response sha256
85f81bf7b60c457e4b5806b47c7c67c745ada2ae114069aa45de5ef977770dba
retrieved at
2026-09-09T23:47:12.730551+00:00
publication date
display
2015 Nov 10
precision
day
year
2015
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26261247/
title
Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis.

Preserved source evidence · Not medical advice